People On Immunomodulatory Therapy Appear To Have Similar Rates Of Breakthrough SARS-CoV-2 Infection To Healthy Controls, Study Indicates

Medwire News (5/12, Barnard) reports, “People on immunomodulatory therapy have similar rates of breakthrough SARS-CoV-2 infection to healthy controls, with a reduced risk seen in those with prior infection or seroconversion after vaccination,” investigato...